首页|1 600例产前超声检查异常胎儿的染色体核型分析、染色体微阵列分析结果观察

1 600例产前超声检查异常胎儿的染色体核型分析、染色体微阵列分析结果观察

扫码查看
目的 观察1 600例产前超声检查异常胎儿的染色体核型分析、染色体微阵列分析(CMA)结果.方法 选取超声检查提示异常的胎儿1 600例,包括结构异常789例和非结构异常811例,分别采用染色体核型分析和CMA,比较两种方法的检测结果及检出率,并对CMA检出的46例致病性染色体微缺失微重复综合征的分子学特征与超声表现结果进行分析.结果 在1 600例超声异常的胎儿中,染色体核型分析检出染色体异常68例,检出率为4.25%(68/1600).CMA共检出异常147例,检出率为9.19%(147/1600),包括临床意义不明的拷贝数变异(VOUS CNV)58例和致病性拷贝数变异(pCNV)89例.两种检测方法检出率比较,P<0.05.789例超声结构异常病例中,染色体核型分析检出异常41例,检出率5.20%(41/789),811例超声非结构异常病例中,染色体核型分析检出异常27例,检出率3.33%(27/811),两组检出率比较,P<0.05.789例超声结构异常病例中,CMA检出pCNV 45例,检出率5.70%(45/789),811例超声非结构异常病例中,CMA检出pCNV 44例,检出率5.43%(44/811),两组检出率比较,P>0.05.应用两种方法均检出相同异常的病例48例,染色体核型分析额外检出15例平衡性结构异常,CMA额外检出39例pCNV,CMA提高致病性检出率2.44%(39/1 600).CMA共检出致病性染色体微缺失微重复46例(其中15例胎儿超声临床表型与其检出的pCNV具有相关性),包括15q微缺失微重复综合征9例,16p11.2微缺失微重复综合征7例,1q21.1微缺失微重复综合征、7q11.23微缺失微重复综合征、16p13.11微缺失微重复综合征各4例,余18例为检出率较低的CNV.结论 染色体核型分析在识别平衡性结构异常及低比例嵌合体异常方面具有优势,CMA对微小结构异常尤其在染色体微缺失微重复的检出具有优势,可大大提高pCNV的检出率,降低产前诊断漏诊率.染色体核型分析和CMA两种方法可以互相弥补,为产前诊断和遗传咨询提供更精准的数据.
Observation on results of chromosomal karyotype analysis and chromosomal microarray analysis of 1 600 fetuses with abnormal prenatal ultrasonography
Objective To observe the results of chromosomal karyotype analysis and chromosomal microarray analy-sis(CMA)in 1 600 fetuses with abnormal prenatal ultrasonography.Methods A total of 1 600 fetuses exhibiting ultra-sonic abnormalities,including 789 cases with structural anomalies and 811 cases with non-structural anomalies,were se-lected for concurrent chromosomal karyotype analysis and CMA detection.The results and detection rates of the two meth-ods were compared,and the molecular characteristics and ultrasonic findings of 46 cases of pathogenic chromosomal micro-deletion/microduplication syndrome identified through CMA were analyzed.Results Among the 1 600 fetuses with ab-normal ultrasound findings,68 cases were identified through chromosomal karyotype analysis,resulting in a detection rate of 4.25%(68/1600).A total of 147 abnormal cases were identified through CMA,comprising 58 cases of copy number variations of unknown clinical significance(VOUS CNVs)and 89 cases of pathogenic copy number variations(pCNVs),resulting in a detection rate of 9.19%(147/1600).Significant difference was found in the detection rate between the two methods(P<0.05).Among the 789 cases exhibiting ultrasonic structural abnormalities,41 cases were identified through chromosome karyotype analysis,resulting in a detection rate of 5.20%(41/789);among the 811 cases presenting ultra-sonic non-structural abnormalities,27 cases were confirmed via chromosome karyotype analysis,yielding a detection rate of 3.33%(27/811);significant difference was found in the detection rate between the two groups(P<0.05).Among the 789 cases exhibiting ultrasonic structural abnormalities,45 cases of pCNV were identified through CMA,resulting in a de-tection rate of 5.70%(45/789).Among the 811 cases with ultrasonic non-structural abnormalities,44 cases of pCNV were detected via CMA,yielding a detection rate of 5.43%(44/811).No significant difference was found in the detection rate between the two groups(P>0.05).Two methods were employed to identify 48 cases with identical abnormalities.Karyotype analysis additionally detected 15 cases of balanced structural abnormalities,and CMA additionally detected 39 cases of pCNV.The use of CMA increased the detection rate of pathogenicity by 2.44%(39/1,600).A total of 46 in-stances of pathogenic chromosomal microdeletions and microduplications were identified through CMA,of which 15 cases exhibited fetal ultrasound phenotypes that correlated with the detected pCNVs.Specifically,this included 9 cases of 15q microdeletion/microduplication syndrome,7 cases of 16p11.5 microdeletion/microduplication syndrome,4 cases each of 1q21.1,7q11.23,and 16p13.11 microdeletion/microduplication syndromes,while the remaining 18 cases were CNVs with a relatively low detection rate.Conclusions The analysis of chromosome karyotype offers advantages in the identifi-cation of balanced structural abnormalities and low-proportion chimera abnormalities.Conversely,CMA provides advantag-es in detecting small structural abnormalities,particularly microdeletions and microduplications,thereby significantly en-hancing the detection rate of pCNV and reducing missed diagnoses in prenatal testing.Chromosomal karyotype analysis and CMA can complement each other to provide more precise data for prenatal diagnosis and genetic counseling.

chromosome microarray analysis techniquechromosome karyotype analysisprenatal diagnosisultra-sonic abnormalitieschromosome microdeletion and microduplication syndrome

马一婧、于彦华、宋旭梅、詹福寿

展开 >

宁夏医科大学总医院医学实验中心,银川 750004

宁夏医科大学第一临床医学院

染色体微阵列分析技术 染色体核型分析 产前诊断 超声异常 染色体微缺失微重复综合征

2024

山东医药
山东卫生报刊社

山东医药

CSTPCD
影响因子:1.225
ISSN:1002-266X
年,卷(期):2024.64(36)